Charles River Laboratories International Inc.

CRL | NYSE

$279.01

+$0.95 (+0.34%)

At close: Sep 21, 2026, 4:00 PM ET

$279.01

$0 (0.00%)

After-hours: Sep 21, 2026, 5:55 PM ET

Fiscal Year Period Ending	FY 2025 Dec 26, 2025	FY 2024 Dec 27, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
PE Ratio	-69.99	930.80	25.50	22.77	48.49	33.99
PEG Ratio	0.05	-9.51	-8.14	0.98	8.49	0.81
PS Ratio	2.51	2.36	2.93	2.78	5.35	4.23
PB Ratio	3.19	2.76	3.37	3.72	7.48	5.85
P/FCF Ratio	19.47	19.07	33.14	37.54	35.62	32.58
P/OCF Ratio	13.68	13.02	17.71	17.87	24.91	22.65
OCF/S Ratio	18.37	18.14	16.56	15.58	21.49	18.69
Debt / Equity Ratio	0.97	0.79	0.85	1.04	1.26	1.02
Quick Ratio	1.02	1.13	1.16	1.08	1.04	1.21
Current Ratio	1.29	1.41	1.52	1.32	1.23	1.43
Asset Turnover	0.56	0.54	0.50	0.52	0.50	0.53
Interest Coverage	4.74	1.80	4.52	10.98	7.98	5.01
Return on Equity	-4.56%	0.30%	13.20%	16.34%	15.42%	17.23%
Return on Assets	-2.02%	0.14%	5.79%	6.40%	5.57%	6.63%
Return on Invested Capital	8.36%	0.94%	7.14%	7.91%	8.12%	7.48%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	30.52%	32.88%	36.39%	36.79%	37.70%	36.72%
Net Profit Margin	-3.59%	0.25%	11.49%	12.23%	11.04%	12.46%
Pretax Profit Margin	-2.48%	2.30%	14.08%	15.67%	13.58%	15.29%
Operating Profit Margin	12.65%	5.61%	14.95%	16.37%	16.66%	14.80%
FCF Margin	12.91%	12.39%	8.85%	7.42%	15.03%	13%
EBITDA Margin	10.23%	14.35%	24.99%	24.80%	23.17%	26.28%